Form D — Nula Therapeutics, Inc.
0002121301-26-000001 · filed 2026-03-18
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $7,399,003
- Total sold
- $7,399,003
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nula Therapeutics, Inc.
- CIK
- 2121301
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 961 Arlington Ave N
St. Petersburg, FL 33705 - Phone
- 212-392-4735
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Shepard · Executive OfficerSt. Petersburg, FL Find on LinkedIn ↗
-
Jarod Rutledge · DirectorSt. Petersburg, FL Find on LinkedIn ↗
-
Nils Regge · DirectorSt. Petersburg, FL Find on LinkedIn ↗
View original on SEC EDGAR.